Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, ESC Scientific Document Group (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European stroke organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816. https://doi.org/10.1093/eurheartj/ehx095
Article
PubMed
Google Scholar
Bisdas T, Beropoulis E, Argyriou A, Torsello G, Stavroulakis K (2018) 1-year all-comers analysis of the eluvia drug-eluting stent for long Femoropopliteal lesions after suboptimal angioplasty. JACC Cardiovasc Interv 11(10):957–966. https://doi.org/10.1016/j.jcin.2018.03.046
Article
PubMed
Google Scholar
Byrne RA, Joner M, Kastrati A (2009) Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol 57(5):567–584
PubMed
CAS
Google Scholar
Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, Moneta GL, Murad MH, Powell RJ, Reed AB, Schanzer A, Sidawy AN (2015) Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication. J Vasc Surg 61(3 Suppl):2S–41S. https://doi.org/10.1016/j.jvs.2014.12.009
Article
PubMed
Google Scholar
Farb A, Heller PF, Shroff S, Cheng L, Kolodgie FD, Carter AJ, Scott DS, Froehlich J, Virmani R (2001) Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104(4):473–479. https://doi.org/10.1161/hc3001.092037
Article
PubMed
CAS
Google Scholar
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME (2017) 2016 AHA/ACC guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 69(11):1465–1508. https://doi.org/10.1016/j.jacc.2016.11.008
Article
PubMed
Google Scholar
Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, Schroeder H, Prem JT, Holden A, Popma J, Jaff MR, Diaz-Cartelle J, Müller-Hülsbeck S (2018) IMPERIAL investigators. A polymer-coated, paclitaxel-eluting stent (eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial. Lancet 392(10157):1541–1551. https://doi.org/10.1016/S0140-6736(18)32262-1
Article
PubMed
CAS
Google Scholar
Ikeoka K, Okayama K, Watanabe T, Nanto S, Sakata Y, Hoshida S (2018) Refractory Vascular Wall healing after paclitaxel-coated Nitinol stent implantation in the Femoropopliteal artery: a high-resolution Angioscopic assessment. Ann Vasc Dis 11(3):373–376. https://doi.org/10.3400/avd.cr.18-00061
Article
PubMed
PubMed Central
Google Scholar
Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, Hosogi S, Hirono A, Tanaka H, Tada T, Morimoto T, Shiomi H, Kozuma K, Inoue K, Suzuki N, Kimura T, Mitsudo K (2011) Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation 123(21):2382–2391. https://doi.org/10.1161/CIRCULATIONAHA.110.003459
Article
PubMed
CAS
Google Scholar
John MC, Wessely R, Kastrati A, Schömig A, Joner M, Uchihashi M, Crimins J, Lajoie S, Kolodgie FD, Gold HK, Virmani R, Finn AV (2008) Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents. JACC Cardiovasc Interv 1(5):535–544. https://doi.org/10.1016/j.jcin.2008.08.004
Article
PubMed
Google Scholar
Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48(1):193–202. https://doi.org/10.1016/j.jacc.2006.03.042
Article
PubMed
Google Scholar
Müller-Hülsbeck S, Benko A, Soga Y, Fujihara M, Iida O, Babaev A, O'Connor D, Zeller T, Dulas DD, Diaz-Cartelle J, Gray WA (2021) Two year efficacy and safety results from the IMPERIAL randomized study of the eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent. Cardiovasc Intervent Radiol 44(3):368–375. https://doi.org/10.1007/s00270-020-02693-1
Article
PubMed
Google Scholar
Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R (2011) Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol 57(4):390–398. https://doi.org/10.1016/j.jacc.2010.05.066
Article
PubMed
CAS
Google Scholar
Sakamoto A, Torii S, Jinnouchi H, Fuller D, Cornelissen A, Sato Y, Kuntz S, Mori M, Kawakami R, Kawai K, Fernandez R, Paek KH, Gadhok N, Guo L, Kolodgie FD, Young B, Ragheb A, Virmani R, Finn AV (2021) Vascular response of a polymer-free, paclitaxel-coated stent (Zilver PTX) versus a polymer-coated, paclitaxel-eluting stent (eluvia) in healthy swine Femoropopliteal arteries. J Vasc Interv Radiol. https://doi.org/10.1016/j.jvir.2021.02.014
Tokuda T, Yamawaki M, Takahara M, Mori S, Makino K, Honda Y, Takafuji H, Takama T, Tsutsumi M, Sakamoto Y, Takimura H, Kobayashi N, Araki M, Hirano K, Ito Y (2016) Comparison of long-term clinical outcomes of lesions exhibiting focal and segmental Peri-stent contrast staining. J Am Heart Assoc 5(3):e002878. https://doi.org/10.1161/JAHA.115.002878
Article
PubMed
PubMed Central
Google Scholar
Tomoi Y, Kuramitsu S, Soga Y, Aihara H, Ando K, Nobuyoshi M (2015) Vascular response after Zilver PTX stent implantation for superficial femoral artery lesions: serial optical coherence tomography findings at 6 and 12 months. J Endovasc Ther 22(1):41–47. https://doi.org/10.1177/1526602814566577
Article
PubMed
Google Scholar
van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, Ellis SG, Topol EJ (1996) Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94(7):1690–1697. https://doi.org/10.1161/01.CIR.94.7.1690
Article
PubMed
Google Scholar
Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109(6):701–705. https://doi.org/10.1161/01.CIR.0000116202.41966.D4
Article
PubMed
Google Scholar
Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, Kolodgie FD, Colombo A (2002) Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 106:2649–2651
Article
CAS
Google Scholar